• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Deep Genomics

Wednesday, June 05, 2024
Platform for Therapeutics
Company Presentation Theater 4
Deep Genomics aims to revolutionize drug development using artificial intelligence built to decode RNA biology and RNA therapeutics. Our proprietary AI platform enables us to decode the enormous complexity of RNA biology to find novel targets, mechanisms, and molecules that are not accessible through traditional methods. Founded in 2015, our multidisciplinary team includes expertise in a diverse range of disciplines including those found in a traditional drug company, as well as machine learning, statistical genetics, applied data science, deep bioinformatics, software engineering and laboratory automation. Deep Genomics is based in Toronto, Ontario and Cambridge, Massachusetts.
Deep Genomics
Company Website: https://www.deepgenomics.com/
Lead Product in Development: Proprietary foundation AI model: BigRNA+

Company HQ City

Cambridge

Company HQ State

MA

Company HQ Country

United States

CEO/Top Company Official

Brian O'Callaghan

Development Phase of Primary Product

Other/Not Applicable
Primary Speaker
Brendan Frey, PhD
Founder, Chief Innovation Officer
Deep Genomics
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS